List view / Grid view
23 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The two studies, FLAIR and ATLAS, will examine the safety and efficacy of monthly dosing with the two-drug, injectable regimen in both treatment-naïve...
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Generic salmeterol is a generic long acting beta‐agonists for the treatment of asthma and COPD, delivered using Vectura’s proprietary dry powder inhalation...
22 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The Institute of Texas award would fund a 3 year global clinical program of clinical trials for adult and paediatric patients acute myeloid leukaemia...
21 November 2016 | By F.P.S. Food and Pharma Systems Srl
FPS is pleased to announce the enlargement of his production plant...
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
FITs are considered to be accurate because unlike other tests, they use immunochemical detection methods that are specific to human haemoglobin...
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
BI 695502, a bevacizumab biosimilar candidate to Avastin, is a monoclonal antibody that may slow or stop the growth of certain tumour types by preventing...
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Sanofi and Regeneron presented results of a Phase 3 study demonstrating the superiority of investigational sarilumab monotherapy versus adalimumab...
21 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A discount to the price of pertuzumab agreed with the company was an important factor in enabling NICE to overturn its earlier provisional decision...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The BRIDGE study involved 245 men with osteoporosis randomised 2:1 to receive either 210 mg romosozumab or placebo subcutaneously once monthly for 1 year...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The FDA granted priority review to the PKC412 (midostaurin) new drug application as treatment for acute myeloid leukaemia...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Around three-quarters (74%) of people believe that a positive test for bacterial infection should be compulsory before being able to access antibiotics...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In more than 700 genotype 1-6 chronic HCV infected patients, 97.5% achieved sustained virologic response at 12 weeks, regardless of baseline viral load...
18 November 2016 | By Niamh Louise Marriott, Digital Content Producer
This conditional marketing authorisation is based on data from the Phase 2 portion of the pivotal JGDG trial and followed a positive recommendation from...
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Opdivo is the first and only Immuno-Oncology treatment proven in a Phase 3 trial to significantly extend overall survival for these patients...
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Genmab’s daratumumab (darazalex) will be investigated in a Phase III clinical study in combination with carfilzomib (kyprolis) and dexamethasone...
